Low Rigidity Gels for MSC Growth Modulation

a low rigidity, stem cell technology, applied in the direction of skeletal/connective tissue cells, biochemistry apparatus and processes, microorganisms, etc., can solve the problems of limited application of adult mesenchymal stem cells, limited expansion and engineering, and out-of-control growth

Pending Publication Date: 2019-07-25
FUNAKI MAKOTO
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention provides methods and compositions that can contribute to the differentiation of mesenchymal stem cells without causing them to become cancer cells or limiting them to a single type of cell. The cells also have the ability to support the growth of hematopoietic cells and can differentiate without contact inhibition. These methods and compositions have the potential to provide a safer and more effective means for regenerative medicine and the development of new treatments for cancer.

Problems solved by technology

Applications of adult mesenchymal stem cells are still limited to preclinical stage at this time, in part because of rapid aging of these cells ex vivo, which limits their expansion and engineering.
However, their ability of unlimited self-renewal may lead to an out-of-control growth, once they are implanted into tissues.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Low Rigidity Gels for MSC Growth Modulation
  • Low Rigidity Gels for MSC Growth Modulation
  • Low Rigidity Gels for MSC Growth Modulation

Examples

Experimental program
Comparison scheme
Effect test

example 1

nt of the Rigidity of Various Tissues and Preparation of Polyacrylamide Gels Approximating the Rigidities of the Tissues

Materials and Experimental Methods

Preparation of Polyacrylamide Gels

[0151]Acrylamide and bisacrylamide (Fisher Biotech, Loughborough, Leicestershire, UK) solutions were prepared to contain a constant polymer mass of 7.5% and bisacrylamide concentrations of 0.01%, 0.03% or 0.3% to alter stiffness. Acrylamide, bisacrylamide, ammonium persulfate, and N,N,N′,N′-tetramethylethylenediamine (TEMED) under a nonaqueous layer of toluene containing 0.5% acrylic acid N-hydroxy succinimide ester (Sigma, St. Louis, Miss.) was polymerized between two coverslips, chemically modified as follows: 200 μl of 0.1 N NaOH was pipetted to cover the surface of a 25-mm-diameter glass cover slip (Fisherbrand, catalog no. 12-545-102; Fisher Scientific, Pittsburgh, Pa.) for 5 min. The NaOH solution was aspirated, and 200 μl of 3-APTMS (3-Aminopropyltrimethoxysilane, Sigma no. 28-1778, Sigma, S...

example 2

e and F-Actin Structure QF hMSC on Soft and Stiff Gels

Materials and Experimental Methods

[0156]hMSC were sparsely seeded on either stiff gels or soft gels coated with collagen type 1 and fibronectin. Cells were incubated for 24 hours in DMEM+10% fetal calf serum, fixed, and stained with Alexa Fluor 488 phalloidin.

Results

[0157]The effect of extracellular matrix rigidity on the shape and F-actin structure of hMSC (human mesenchymal stem cells) was investigated. Cells were incubated in the presence of serum on matrices with various rigidities for 24 hours to allow adherence and spreading. hMSC seeded on stiff gels or glass adopted a spindle shape and exhibited stress fibers and cortical F-actin (as shown by Alexa Fluor 488 phalloidin staining), whereas cells seeded on soft gels exhibited a rounded appearance, lacked stress fibers, and contained F-actin aggregates (FIG. 1B-1C).

[0158]Thus, hMSC sense the rigidity of the extracellular matrix, which influences their shape and F-actin struct...

example 3

n of hMSC Proliferation on Soft Gels

Materials and Experimental Methods

[0159]hMSC were incubated with BrdU (Invitrogen, Carlsbad, Calif.) overnight in the presence of serum. Cells were fixed and immunostained for BrdU (Invitrogen). More than 50 cells were counted for three times in randomly chosen fields.

Results

[0160]5-bromo-2′-deoxyuridine 5′-triphosphate (BrdU) incorporation was measured in hMSC as a marker of cell cycle progression (FIG. 2). Cells were seeded sparsely on soft gels, stiff gels or glass surfaces, all of which were coated with collagen type 1 and fibronectin. As a control, confluent cells on glass surface were also prepared. As expected, hMSC sparsely seeded on glass surfaces efficiently incorporated BrdU, indicating a high level of proliferation. When cells were confluent on glass surface, very few hMSC incorporated BrdU due to a contact inhibition. 42% of hMSC on stiff gels incorporated BrdU, indicating a large population of cells was proliferating, although signif...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

This invention provides gels and matrices having a rigidity in the range of 0.1-2.5 kPa, methods of manufacturing same, and method of preserving a mesenchymal stem cell population or studying mesenchymal stem cells, comprising same.

Description

FIELD OF INVENTION[0001]This invention provides methods of modulating stem cell development using soft-gels. Specifically, the invention provides methods, compositions and devices for modulating the development of stem cells, using gels having optimized viscoelastic properties.BACKGROUND OF THE INVENTION[0002]Adult mesenchymal stem cells have the ability to self-renew and differentiate into multiple cell lineages of mesenchymal tissues. Therefore, clinical applications of these cells, such as replacement of damaged tissues or carriers for anti-cancer agents, have been considered. Applications of adult mesenchymal stem cells are still limited to preclinical stage at this time, in part because of rapid aging of these cells ex vivo, which limits their expansion and engineering. Immortalizing mesenchymal stem cells by telomerase transduction is reported to overcome issues associated with accelerated aging. However, their ability of unlimited self-renewal may lead to an out-of-control gr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): C12N5/00C12N5/0775
CPCC12N5/0068C12N5/0663C12N2533/52C12N2533/30C12N2533/54
Inventor FUNAKI, MAKOTOWINER, JESSAMINE
Owner FUNAKI MAKOTO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap